+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biodegradable Metal Vascular Stent Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Biodegradable Metal Vascular Stent Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Biodegradable Metal Vascular Stent Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6079472
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The advent of biodegradable metal vascular stents marks a paradigm shift in endovascular therapies, offering a blend of mechanical support and gradual resorption that aligns with the body’s natural healing processes. Unlike permanent metallic scaffolds, these next-generation implantable devices dissolve over time, reducing long-term complications such as chronic inflammation, late stent thrombosis and restenosis. Over the past decade, research has pivoted toward magnesium-, iron- and zinc-based alloys that deliver controlled degradation rates, optimized radial strength and enhanced biocompatibility. This executive summary synthesizes current industry dynamics, explores regulatory and economic headwinds, and unveils critical market segments and regional drivers. It empowers stakeholders-including medical device manufacturers, clinical practitioners, investors and policy strategists-to navigate complex supply chains, catalyze innovation and seize emerging opportunities in the biodegradable metal vascular stent arena.

Transformative Shifts Reshaping the Vascular Stent Landscape

Breakthroughs in materials science and clinical protocols have catalyzed transformative changes in vascular device technology. The rise of magnesium-alloy scaffolds with tailored corrosion rates has enabled shorter dual antiplatelet therapy durations, enhancing patient safety profiles. Concurrently, advances in surface-coating techniques-such as bioactive polymer layers and drug-eluting films-have refined degradation timelines while mitigating inflammatory responses. Clinicians are increasingly adopting image-guided, minimally invasive procedures that leverage high-resolution intravascular ultrasound and optical coherence tomography to ensure precise stent placement. On the regulatory front, accelerated pathways and harmonized international standards have shortened approval cycles, incentivizing rapid iteration of stent designs. Furthermore, an aging population with a growing prevalence of comorbidities has intensified demand for durable solutions that address both cardiac and peripheral vascular disease. As digital health platforms proliferate, remote monitoring and data analytics are poised to inform personalized treatment algorithms, fostering a shift from one-size-fits-all devices to patient-centric stent therapies.

Cumulative Effects of 2025 U.S. Tariffs on Supply Chains and Costs

The introduction of new U.S. tariffs on key raw metals in early 2025-targeting magnesium, iron and specialty alloy imports-has altered cost structures across the supply chain. Manufacturers face upward pressure on component pricing, prompting contract renegotiations with suppliers and exploration of domestic sourcing alternatives. Some firms have absorbed additional expenses to maintain competitive pricing, while others have revisited alloy formulations to balance performance with cost efficiency. These duties have further incentivized investment in localized production facilities, reducing reliance on volatile international markets. Meanwhile, endovascular device makers must navigate potential shifts in customer procurement strategies, as hospitals and health systems weigh higher implant costs against long-term patient outcomes. To mitigate margin erosion, companies are accelerating modular manufacturing techniques and partnering with freight logistics specialists to optimize inventory management. As a result of these cumulative tariff impacts, strategic agility in procurement, manufacturing and distribution has become paramount for sustaining growth and ensuring affordability of biodegradable stent therapies.

Key Segmentation Insights Revealing Market Dynamics

A nuanced examination of key market segments reveals distinct growth drivers and technical priorities. Within the product profile domain, material composition is under intense scrutiny as magnesium-based alloys lead initial adoption, while iron- and zinc-based alternatives progress through preclinical stages; structural design innovations-ranging from coil-shaped scaffolds to helical strut geometries-seek to optimize vessel compliance; advanced surface coatings incorporate drug-eluting polymers that regulate neointimal proliferation. In application areas, participants are concentrating on expanding indications for cardiac disorders beyond acute coronary syndrome to include small-vessel disease, even as peripheral vascular disease applications-such as treatment of superficial femoral arteries-gain clinical traction. Patient profile segmentation is driving tailored deployment strategies: adult patients with stable angina benefit from rapid bioresorption, whereas elderly or high-risk populations with multiple comorbidities demand stents with prolonged structural integrity; those presenting complex lesion profiles necessitate bespoke device characteristics. Technology adoption patterns show a bifurcation between institutions prioritizing innovative procedural workflows that integrate robotic assistance and those emphasizing efficiency in cath lab throughput. Clinical outcome segmentation focuses on optimizing biocompatibility metrics, fine-tuning degradation timelines to align with endothelial healing, and minimizing restenosis rates. Finally, investment opportunities are flourishing in both clinical trial funding-supporting pivotal safety and efficacy studies-and research and development partnerships that propel next-generation prototypes toward regulatory submission.

Key Regional Insights Highlighting Growth Drivers

Regional landscapes exhibit unique drivers shaping market expansion. In the Americas, robust reimbursement frameworks and substantial healthcare R&D budgets accelerate clinical adoption of cutting-edge biodegradable stents, with the United States leading in pivotal clinical trial activity. Meanwhile, Latin American markets are gradually building regulatory capacity, fostering partnerships between global manufacturers and local distributors to improve access. Across Europe, Middle East & Africa, harmonized EU medical device regulations coexist with divergent national pathways, prompting device makers to pursue CE marking early while customizing launch strategies for markets like Germany, France and the Gulf Cooperation Council. In Africa, infrastructure gaps slow uptake but create opportunities for cost-effective, low-resource deployment models. The Asia-Pacific region demonstrates the fastest growth trajectory, driven by rising cardiovascular disease prevalence in China, Japan’s focus on advanced bioresorbable materials, and emerging market investments in India’s private healthcare sector. Collaborative efforts between regional governments, academic research centers and multinational corporations are paving the way for streamlined approvals and large-scale manufacturing hubs.

Key Company Insights Demonstrating Competitive Landscapes

Competition within the biodegradable metal stent space encompasses established medtech giants and agile disruptors. Abbott Laboratories leverages extensive alloy expertise and a robust global supply chain to expedite product rollouts, while Boston Scientific Corporation and Johnson & Johnson Medical Devices capitalize on integrated device portfolios to bundle stent solutions with adjunctive imaging and pharmacotherapy. Medtronic, Inc. and Biotronik SE & Co. KG emphasize post-market surveillance and real-world evidence to refine safety profiles and support label expansions. B. Braun Melsungen AG integrates its proprietary surface-modification platforms, collaborating with academic centers to advance in-vivo corrosion studies. A wave of specialized players-including BioAbsorb Medical Inc., BioMetallic Systems, Inc. and EcoStent Therapeutics-focuses on novel alloy formulations and next-generation polymer coatings. Meanwhile, innovative companies such as ReNovo Vascular Systems, Renova Cardio Devices and SynerBio Stent Technologies are forging strategic alliances and securing early-stage funding, accelerating their entry into pivotal clinical trials. Niche firms like PolyMet Biohealth, Inc. and BioGraft Vascular Inc. are also driving R&D innovation, while larger conglomerates such as Terumo Corporation and W.L. Gore & Associates (Gore Medical) explore acquisitions to integrate bioresorbable stent platforms within their vascular portfolios. The emerging cohort of FutureStent Medical, Innovascular Solutions Ltd., MicroPort Scientific Corporation and EndoVita Medical Technologies further underscores the intensity of market consolidation and the premium placed on intellectual property.

Actionable Recommendations for Industry Leaders

To successfully navigate this evolving environment, industry leaders should prioritize several strategic imperatives:
  • Intensify investment in preclinical research to develop alloy compositions with tunable degradation rates, balancing radial strength and resorption timelines.
  • Establish strategic partnerships with tertiary care centers to expedite enrollment in multicenter clinical trials, generating robust safety and efficacy data for regulatory submissions.
  • Diversify sourcing by cultivating domestic raw material suppliers and forging long-term contracts, thereby mitigating tariff-induced cost volatility.
  • Integrate digital health tools, such as remote monitoring platforms and AI-driven analytics, to enhance patient outcomes and support value-based contracting with payers.
  • Expand presence in high-growth Asia-Pacific and select Latin American markets through co-development agreements and adaptive licensing strategies.
  • Pursue targeted acquisitions of niche innovators to secure intellectual property around next-generation coatings and strut geometries.

Conclusion: Positioning for Future Growth

The biodegradable metal vascular stent sector stands at a pivotal juncture. Advances in materials science, regulatory alignment and clinical insights converge to redefine patient care pathways, while economic headwinds and tariff pressures demand resilient supply chain strategies. As market maturation accelerates, stakeholders who adeptly integrate cutting-edge R&D, data-driven decision-making and proactive collaborations will unlock the full potential of bioresorbable stent therapies. By maintaining a sharp focus on patient outcomes, regulatory compliance and cost optimization, manufacturers can secure sustainable growth and deliver transformative cardiovascular solutions.

Market Segmentation & Coverage

This research report categorizes the Biodegradable Metal Vascular Stent Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Material Composition
  • Structural Design
  • Surface Coating
  • Cardiac Disorders
  • Peripheral Vascular Diseases
  • Adult
  • Comorbidities
  • Elderly
  • High Risk Conditions
  • Innovative Approaches
  • Procedure Efficiency
  • Biocompatibility
  • Degradation Timeline
  • Restenosis Rate
  • Clinical Trials Funding
  • Research And Development

This research report categorizes the Biodegradable Metal Vascular Stent Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Biodegradable Metal Vascular Stent Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BioAbsorb Medical Inc.
  • BioEntreStent Solutions
  • BioGraft Vascular Inc.
  • BioMetallic Systems, Inc.
  • BioStent Technologies, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • EcoStent Therapeutics
  • EndoVita Medical Technologies
  • FutureStent Medical
  • Innovascular Solutions Ltd.
  • Johnson & Johnson Medical Devices
  • MedEco Innovations LLC
  • Medtronic, Inc.
  • MicroPort Scientific Corporation
  • NextGen Vascular Solutions
  • PolyMet Biohealth, Inc.
  • ProBioTech Medical Devices
  • Renova Cardio Devices
  • ReNovo Vascular Systems
  • RESILIENT Medical Innovations, Inc.
  • SynerBio Stent Technologies
  • Terumo Corporation
  • VascuBio Medical, LLC
  • VascuCore BioMedical, Inc.
  • Vascular Bioengineering Corp.
  • Vascular Renewal Inc.
  • W.L. Gore & Associates (Gore Medical)

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biodegradable Metal Vascular Stent Market, by Product Profile
8.1. Introduction
8.2. Material Composition
8.3. Structural Design
8.4. Surface Coating
9. Biodegradable Metal Vascular Stent Market, by Application Area
9.1. Introduction
9.2. Cardiac Disorders
9.3. Peripheral Vascular Diseases
10. Biodegradable Metal Vascular Stent Market, by Patient Profile
10.1. Introduction
10.2. Adult
10.3. Comorbidities
10.4. Elderly
10.5. High Risk Conditions
11. Biodegradable Metal Vascular Stent Market, by Technology Adoption
11.1. Introduction
11.2. Innovative Approaches
11.3. Procedure Efficiency
12. Biodegradable Metal Vascular Stent Market, by Clinical Outcome
12.1. Introduction
12.2. Biocompatibility
12.3. Degradation Timeline
12.4. Restenosis Rate
13. Biodegradable Metal Vascular Stent Market, by Investment Opportunities
13.1. Introduction
13.2. Clinical Trials Funding
13.3. Research And Development
14. Americas Biodegradable Metal Vascular Stent Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Biodegradable Metal Vascular Stent Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Biodegradable Metal Vascular Stent Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. B. Braun Melsungen AG
17.3.3. BioAbsorb Medical Inc.
17.3.4. BioEntreStent Solutions
17.3.5. BioGraft Vascular Inc.
17.3.6. BioMetallic Systems, Inc.
17.3.7. BioStent Technologies, Inc.
17.3.8. Biotronik SE & Co. KG
17.3.9. Boston Scientific Corporation
17.3.10. EcoStent Therapeutics
17.3.11. EndoVita Medical Technologies
17.3.12. FutureStent Medical
17.3.13. Innovascular Solutions Ltd.
17.3.14. Johnson & Johnson Medical Devices
17.3.15. MedEco Innovations LLC
17.3.16. Medtronic, Inc.
17.3.17. MicroPort Scientific Corporation
17.3.18. NextGen Vascular Solutions
17.3.19. PolyMet Biohealth, Inc.
17.3.20. ProBioTech Medical Devices
17.3.21. Renova Cardio Devices
17.3.22. ReNovo Vascular Systems
17.3.23. RESILIENT Medical Innovations, Inc.
17.3.24. SynerBio Stent Technologies
17.3.25. Terumo Corporation
17.3.26. VascuBio Medical, LLC
17.3.27. VascuCore BioMedical, Inc.
17.3.28. Vascular Bioengineering Corp.
17.3.29. Vascular Renewal Inc.
17.3.30. W.L. Gore & Associates (Gore Medical)
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIODEGRADABLE METAL VASCULAR STENT MARKET MULTI-CURRENCY
FIGURE 2. BIODEGRADABLE METAL VASCULAR STENT MARKET MULTI-LANGUAGE
FIGURE 3. BIODEGRADABLE METAL VASCULAR STENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIODEGRADABLE METAL VASCULAR STENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIODEGRADABLE METAL VASCULAR STENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIODEGRADABLE METAL VASCULAR STENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY MATERIAL COMPOSITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY STRUCTURAL DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY SURFACE COATING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CARDIAC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PERIPHERAL VASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY COMORBIDITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY HIGH RISK CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INNOVATIVE APPROACHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PROCEDURE EFFICIENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY BIOCOMPATIBILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY DEGRADATION TIMELINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY RESTENOSIS RATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL TRIALS FUNDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 47. CANADA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 48. CANADA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 49. CANADA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 50. CANADA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 51. CANADA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 52. CANADA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 53. MEXICO BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 54. MEXICO BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 55. MEXICO BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 57. MEXICO BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 58. MEXICO BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 79. CHINA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 80. CHINA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 81. CHINA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 82. CHINA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 83. CHINA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 84. CHINA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 85. INDIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 86. INDIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 87. INDIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 88. INDIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 89. INDIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 90. INDIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 97. JAPAN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 98. JAPAN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 99. JAPAN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 100. JAPAN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 101. JAPAN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 102. JAPAN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 133. THAILAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 134. THAILAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 135. THAILAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 136. THAILAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 137. THAILAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 138. THAILAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 152. DENMARK BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 153. DENMARK BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 154. DENMARK BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 155. DENMARK BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 156. DENMARK BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 157. DENMARK BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 158. EGYPT BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 159. EGYPT BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 160. EGYPT BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 161. EGYPT BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 162. EGYPT BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 163. EGYPT BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 164. FINLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 165. FINLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 166. FINLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 167. FINLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 168. FINLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 169. FINLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 170. FRANCE BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 171. FRANCE BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 172. FRANCE BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 173. FRANCE BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 174. FRANCE BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 175. FRANCE BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 176. GERMANY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 177. GERMANY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 178. GERMANY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 179. GERMANY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 180. GERMANY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 181. GERMANY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 188. ITALY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 189. ITALY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 190. ITALY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 191. ITALY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 192. ITALY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 193. ITALY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 206. NORWAY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 207. NORWAY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 208. NORWAY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 209. NORWAY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 210. NORWAY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 211. NORWAY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 212. POLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 213. POLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 214. POLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 215. POLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 216. POLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 217. POLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 218. QATAR BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 219. QATAR BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 220. QATAR BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 221. QATAR BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 222. QATAR BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 223. QATAR BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 242. SPAIN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 243. SPAIN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 244. SPAIN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 245. SPAIN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 246. SPAIN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 247. SPAIN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 260. TURKEY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 261. TURKEY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 262. TURKEY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 263. TURKEY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 264. TURKEY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 265. TURKEY BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PRODUCT PROFILE, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY PATIENT PROFILE, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY TECHNOLOGY ADOPTION, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY CLINICAL OUTCOME, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM BIODEGRADABLE METAL VASCULAR STENT MARKET SIZE, BY INVESTMENT OPPORTUNITIES, 2018-2030 (USD MILLION)
TABLE 278. BIODEGRADABLE METAL VASCULAR STENT MARKET SHARE, BY KEY PLAYER, 2024
TABLE 279. BIODEGRADABLE METAL VASCULAR STENT MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BioAbsorb Medical Inc.
  • BioEntreStent Solutions
  • BioGraft Vascular Inc.
  • BioMetallic Systems, Inc.
  • BioStent Technologies, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • EcoStent Therapeutics
  • EndoVita Medical Technologies
  • FutureStent Medical
  • Innovascular Solutions Ltd.
  • Johnson & Johnson Medical Devices
  • MedEco Innovations LLC
  • Medtronic, Inc.
  • MicroPort Scientific Corporation
  • NextGen Vascular Solutions
  • PolyMet Biohealth, Inc.
  • ProBioTech Medical Devices
  • Renova Cardio Devices
  • ReNovo Vascular Systems
  • RESILIENT Medical Innovations, Inc.
  • SynerBio Stent Technologies
  • Terumo Corporation
  • VascuBio Medical, LLC
  • VascuCore BioMedical, Inc.
  • Vascular Bioengineering Corp.
  • Vascular Renewal Inc.
  • W.L. Gore & Associates (Gore Medical)

Methodology

Loading
LOADING...

Related Topics

Related Reports

Vascular Stent Market by Product Type (Balloon-Expandable Stents, Self-Expanding Stents), Material (Metallic Stents, Polymeric Stents), Delivery System, Application, End User - Global Forecast 2025-2030 - Product Image

Vascular Stent Market by Product Type (Balloon-Expandable Stents, Self-Expanding Stents), Material (Metallic Stents, Polymeric Stents), Delivery System, Application, End User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Biodegradable Stents Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030 - Product Image

Biodegradable Stents Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Vascular Stent Market by Technology (Dug-eluting, Covered), Product (Coronary, Peripheral (Carotid, Renal)), MOD (Balloon-expandable, Self-expanding), Material (Metal (PtCr,CoCr), Polymer), End User (Hospitals, Cardiac Center) - Global Forecast to 2029 - Product Image

Vascular Stent Market by Technology (Dug-eluting, Covered), Product (Coronary, Peripheral (Carotid, Renal)), MOD (Balloon-expandable, Self-expanding), Material (Metal (PtCr,CoCr), Polymer), End User (Hospitals, Cardiac Center) - Global Forecast to 2029

  • Report
  • 427 Pages
  • Global
From
Non-vascular Stent Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Non-vascular Stent Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 81 Pages
  • Global
From
Non-Vascular Stents - Global Strategic Business Report - Product Image

Non-Vascular Stents - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.